145 related articles for article (PubMed ID: 21122582)
1. Rectal non-Hodgkin's lymphoma in an infliximab treated patient with ulcerative colitis and primary sclerosing cholangitis.
Van Hauwaert V; Meers S; Verhoef G; Tousseyn T; Sagaert X; Vermeire S; Rutgeerts P; Van Assche G
J Crohns Colitis; 2010 Dec; 4(6):683-6. PubMed ID: 21122582
[TBL] [Abstract][Full Text] [Related]
2. Dysplasia and colorectal cancer in a patient with ulcerative colitis and primary sclerosing cholangitis: a case report and a short review of the literature.
Chaparro M; Trapero-Marugán M; Guijarro M; López C; Moreno-Otero R; Gisbert JP
J Crohns Colitis; 2013 Mar; 7(2):e61-5. PubMed ID: 22552273
[TBL] [Abstract][Full Text] [Related]
3. [Rectal diffuse large B cell lymphoma appearing after immunosuppression for ulcerative colitis. Report of one case].
Quera R; Flores L; Simian D; Kronberg U; Vial MT; de Guevara DL; García-Rodríguez MJ
Rev Med Chil; 2017 Oct; 145(10):1342-1348. PubMed ID: 29488576
[TBL] [Abstract][Full Text] [Related]
4. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
[TBL] [Abstract][Full Text] [Related]
5. Rectal lymphoma in ulcerative colitis treated with azathioprine.
Tan CW; Wilson GE; Howat JM; Shreeve DR
Eur J Gastroenterol Hepatol; 2001 Aug; 13(8):989-92. PubMed ID: 11507370
[TBL] [Abstract][Full Text] [Related]
6. Infliximab for ulcerative colitis following liver transplantation.
Lal S; Steinhart AH
Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):277-80. PubMed ID: 17301656
[TBL] [Abstract][Full Text] [Related]
7. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis.
Navaneethan U; Kochhar G; Venkatesh PG; Bennett AE; Rizk M; Shen B; Kiran RP
J Crohns Colitis; 2013 Dec; 7(12):974-81. PubMed ID: 23523416
[TBL] [Abstract][Full Text] [Related]
8. Lack of efficacy of infliximab in the treatment of primary sclerosing cholangitis in inflammatory bowel diseases in childhood.
Cardile S; Candusso M; Papadatou B; Bracci F; Knafelz D; Torre G
Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):736. PubMed ID: 28441268
[No Abstract] [Full Text] [Related]
9. Steroid-refractory ulcerative colitis and associated primary sclerosing cholangitis treated with infliximab.
Duca I; Ramírez de la Piscina P; Estrada S; Calderón R; Spicakova K; Urtasun L; Marra-López C; Zabaleta S; Bengoa R; Marcaide MA; García-Campos F
World J Gastroenterol; 2013 Jan; 19(4):590-3. PubMed ID: 23382642
[TBL] [Abstract][Full Text] [Related]
10. Colitis-associated sclerosing cholangitis in children: a single centre experience.
Noble-Jamieson G; Heuschkel RB; Torrente F; Hadzic N; Zilbauer M
J Crohns Colitis; 2013 Nov; 7(10):e414-8. PubMed ID: 23485432
[TBL] [Abstract][Full Text] [Related]
11. A review of infliximab use in ulcerative colitis.
Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
[TBL] [Abstract][Full Text] [Related]
12. Effects of vedolizumab, adalimumab and infliximab on biliary inflammation in individuals with primary sclerosing cholangitis and inflammatory bowel disease.
Tse CS; Loftus EV; Raffals LE; Gossard AA; Lightner AL
Aliment Pharmacol Ther; 2018 Jul; 48(2):190-195. PubMed ID: 29808485
[TBL] [Abstract][Full Text] [Related]
13. Mucin-producing carcinoma of the gallbladder associated with primary sclerosing cholangitis and ulcerative colitis.
Noda H; Chiba F; Toyama N; Konishi F
J Hepatobiliary Pancreat Surg; 2009; 16(1):83-5. PubMed ID: 19096754
[TBL] [Abstract][Full Text] [Related]
14. Temporal trends in colon neoplasms in patients with primary sclerosing cholangitis and ulcerative colitis.
Navaneethan U; Venkatesh PG; Lashner BA; Remzi FH; Shen B; Kiran RP
J Crohns Colitis; 2012 Sep; 6(8):845-51. PubMed ID: 22398080
[TBL] [Abstract][Full Text] [Related]
15. Paradoxical progression of biliary strictures against recovery of biochemical parameters under ursodeoxycholic acid treatment in a case of primary sclerosing cholangitis with ulcerative colitis.
Komatsu K; Shimosegawa T; Kikuchi S; Uchi M; Maruhama Y; Kisara N; Ueno Y; Toyota T
Intern Med; 2000 Dec; 39(12):1049-53. PubMed ID: 11197788
[TBL] [Abstract][Full Text] [Related]
16. Diffuse gastroduodenitis associated with ulcerative colitis: treatment by infliximab.
Chiba M; Ono I; Wakamatsu H; Wada I; Suzuki K
Dig Endosc; 2013 Nov; 25(6):622-5. PubMed ID: 24164601
[TBL] [Abstract][Full Text] [Related]
17. Development of testicular germ cell cancer following successful infliximab induction therapy for ulcerative colitis.
Wong JC; Bressler B; Salh B; Yoshida EM; Chatur N
J Crohns Colitis; 2011 Apr; 5(2):162-4. PubMed ID: 21453887
[TBL] [Abstract][Full Text] [Related]
18. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
Colombel JF; Rutgeerts P; Reinisch W; Esser D; Wang Y; Lang Y; Marano CW; Strauss R; Oddens BJ; Feagan BG; Hanauer SB; Lichtenstein GR; Present D; Sands BE; Sandborn WJ
Gastroenterology; 2011 Oct; 141(4):1194-201. PubMed ID: 21723220
[TBL] [Abstract][Full Text] [Related]
19. Effective use of switching biologics for ulcerative colitis complicated with pyoderma gangrenosum and primary sclerosing cholangitis.
Iwahashi K; Kuroki Y; Takano Y; Nagahama M
BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 33958364
[TBL] [Abstract][Full Text] [Related]
20. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
Yamamoto-Furusho JK; Uzcanga LF
Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
